Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iGlarLixi vs Glargine + Dulaglutide in T2D
NCT04893148Phase 4Unknown
- Sponsor
- Chungbuk National University Hospital
- Start
- May 2020
- Primary completion
- Dec 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine + lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Chungbuk National University Hospital. Status: unknown.
02
Drugs
insulin glargine + lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04893148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04893148.